CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 130 filers reported holding CASTLE BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,815 | +23.1% | 1,410 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,345 | -39.6% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $32,035 | -3.5% | 1,410 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $33,191 | -9.7% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $36,773 | +18.8% | 1,410 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $30,950 | -51.1% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $63,253 | -75.3% | 1,410 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $256,148 | -35.5% | 5,975 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $397,338 | -9.3% | 5,975 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $438,147 | +51.4% | 5,975 | +41.4% | 0.01% | +50.0% |
| Q1 2021 | $289,380 | +32.2% | 4,227 | +29.7% | 0.00% | +33.3% |
| Q4 2020 | $218,842 | +30.5% | 3,259 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $167,676 | +36.5% | 3,259 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $122,832 | +26.4% | 3,259 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $97,151 | – | 3,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |